A GEE approach to estimating accuracy and its confidence intervals for correlated data.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 59, doi. 10.1002/pst.1970
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2020 AND VI 19 AND IP 1
Results: 7
1
2
Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion—With an application to the design of a clinical trial in acute myeloid leukemia.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 44, doi. 10.1002/pst.1969
- By:
- Publication type:
- Article
3
An exact test for comparing two predictive values in small‐size clinical trials.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 31, doi. 10.1002/pst.1968
- By:
- Publication type:
- Article
4
Optimal designs for regional bridging studies using the Bayesian power prior method.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 22, doi. 10.1002/pst.1967
- By:
- Publication type:
- Article
5
Bayesian sample‐size determination methods considering both worthwhileness and unpromisingness for exploratory two‐arm randomized clinical trials with binary endpoints.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 71, doi. 10.1002/pst.1971
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 1, doi. 10.1002/pst.1957
- Publication type:
- Article
7
Planning and analyzing clinical trials with competing risks: Recommendations for choosing appropriate statistical methodology.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 1, p. 4, doi. 10.1002/pst.1966
- By:
- Publication type:
- Article